Residues crucial for Ras interaction with GDP-GTP exchangers
- PMID: 8516302
- PMCID: PMC46761
- DOI: 10.1073/pnas.90.12.5564
Residues crucial for Ras interaction with GDP-GTP exchangers
Abstract
Cdc25 is essential for Ras-mediated activation of adenylyl cyclase in the yeast Saccharomyces cerevisiae. This protein acts by catalyzing GDP-GTP exchange on yeast Ras. Harvey (Ha) ras expressed in S. cerevisiae is also recognized by both Cdc25 and Sdc25, a yeast homolog of Cdc25. Thus it is feasible to examine molecular aspects of mammalian Ras modulation by Cdc25 using the RAS/cAMP pathway in yeast as a model system. Here, we describe mutational analysis of Ha-ras for the identification of residues critical for the ability of Ras to interact with Cdc25 and related guanine nucleotide-release proteins. Mutations within codons 97-108 impaired Ras-mediated activation of adenylyl cyclase in the presence but not in the absence of mammalian GTPase-activating protein. Such mutations, therefore, affected the ability of Ras to undergo GDP-GTP exchange catalyzed by the guanine nucleotide exchanger without preventing Ras activation of the effector. Similar mutations were previously shown to impair the ability of c-ras to transform mammalian cells while having a less drastic effect on v-ras.
Similar articles
-
A mouse CDC25-like product enhances the formation of the active GTP complex of human ras p21 and Saccharomyces cerevisiae RAS2 proteins.J Biol Chem. 1992 Dec 5;267(34):24181-3. J Biol Chem. 1992. PMID: 1447167
-
Interaction between the Saccharomyces cerevisiae CDC25 gene product and mammalian ras.J Biol Chem. 1992 Nov 15;267(32):22747-51. J Biol Chem. 1992. PMID: 1429624
-
Saccharomyces cerevisiae CDC25 (1028-1589) is a guanine nucleotide releasing factor for mammalian ras proteins and is oncogenic in NIH3T3 cells.J Biol Chem. 1993 May 25;268(15):11113-8. J Biol Chem. 1993. PMID: 8388382
-
The many roads that lead to Ras.Science. 1993 May 7;260(5109):767-8. doi: 10.1126/science.8484117. Science. 1993. PMID: 8484117 Review. No abstract available.
-
Ras-regulated signaling processes in Saccharomyces cerevisiae.Curr Opin Genet Dev. 1991 Oct;1(3):370-7. doi: 10.1016/s0959-437x(05)80302-8. Curr Opin Genet Dev. 1991. PMID: 1668647 Review.
Cited by
-
Targeting signal transduction for disease therapy.Med Oncol. 1997 Jun;14(2):83-9. doi: 10.1007/BF02990952. Med Oncol. 1997. PMID: 9330267 Review.
-
Decreased GTPase activity of K-ras mutants deriving from human functional adrenocortical tumours.Br J Cancer. 2000 Mar;82(5):1035-40. doi: 10.1054/bjoc.1999.1039. Br J Cancer. 2000. PMID: 10737386 Free PMC article.
-
Identification of residues critical for Ras(17N) growth-inhibitory phenotype and for Ras interaction with guanine nucleotide exchange factors.Mol Cell Biol. 1994 Feb;14(2):1113-21. doi: 10.1128/mcb.14.2.1113-1121.1994. Mol Cell Biol. 1994. PMID: 8289792 Free PMC article.
-
A novel HRAS substitution (c.266C>G; p.S89C) resulting in decreased downstream signaling suggests a new dimension of RAS pathway dysregulation in human development.Am J Med Genet A. 2012 Sep;158A(9):2106-18. doi: 10.1002/ajmg.a.35449. Epub 2012 Jul 20. Am J Med Genet A. 2012. PMID: 22821884 Free PMC article.
-
Differential activation of yeast adenylyl cyclase by Ras1 and Ras2 depends on the conserved N terminus.Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11009-13. doi: 10.1073/pnas.92.24.11009. Proc Natl Acad Sci U S A. 1995. PMID: 7479926 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
